mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigations

Print PDF Icon
Authored by Dan Shores for

IP, the largest online intellectual property publication in the world and a leading source for news, information, analysis, and commentary in the patent and innovation industries published an article authored by partner Dan Shores entitled "mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigations."

Substantial patent litigation activity occurred in the mRNA space in 2022, involving nearly all of the major mRNA and lipid nanoparticle (LNP) pioneers. Since this is the most significant happening in this space with respect to IP in 2022, the article provides an overview of that activity as well as a summary exposure analysis.

To read the full article, please visit the website.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.